Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Which drug calms kids better after eye surgery?

NCT ID NCT06312618

Symptom relief Sponsor: Ain Shams University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This trial tested two drugs, propofol and dexmedetomidine, to see which better prevents emergence agitation—a state of restlessness and crying—in children aged 3 to 7 after squint surgery. Eighty children were randomly given one of the drugs after anesthesia. The goal is to find a safer, more effective way to keep kids calm as they wake up.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
propofol and dexmedetomidine
What this could lead to
If one drug proves better, it could become the standard choice to prevent agitation in children after eye surgery.
What could go wrong
This is a small, completed Phase 4 trial with only 80 children. Results may not apply to all surgeries or ages.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 4

Runs after approval, following long-term safety and how well the treatment works in everyday use.

Participants

80 people

The number who actually took part.

Started

Mar 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

3 to 7 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Pediatric patients from 3 to 7 years. * American Society of Anesthesiologists (ASA) Physical Status Class-I and II. * Patients undergo squint surgery. Exclusion Criteria: * Declining to give written informed consent by patient legal guardian. * Age younger than 3 years or older than 7 years. * ASA classification ≥ III. * History of allergy to the medications used in the study or egg products. * Psychiatric disorder * Other co-morbidities or congenital anomalies or neurological.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Emergence agitation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Emergence Delirium strabismus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Emergence agitation

Contacts and locations

Locations

  • Ain Shams University

    Cairo, Cairo Governorate, 11517, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.